Nisha Loganantharaj (@nloganmd) 's Twitter Profile
Nisha Loganantharaj

@nloganmd

IBD specialist @LSUHealthNO @UMCNO Tweets are my own 🚫medical advice

ID: 1504874219112382466

calendar_today18-03-2022 17:35:58

553 Tweet

424 Followers

452 Following

Beatriz Gros (@bealoquebea) 's Twitter Profile Photo

I know I’m a bit late, but here’s the updated table of #IBD treatments with their doses & routes of administration with the addition of guselkumab Full quality table➡️ ibd-eii.com/ibdcheatsheet/

I know I’m a bit late, but here’s the updated table of #IBD treatments with their doses & routes of administration with the addition of guselkumab

Full quality table➡️ ibd-eii.com/ibdcheatsheet/
Edward Barnes MD MPH (@edbarnesmd) 's Twitter Profile Photo

I believe there's an opportunity to re-evaluate our approach to patients after #IPAA for #UC. #HansHerfarth and I discuss moving from a reactive ➡️ proactive approach in CGH UNC Gastroenterology cghjournal.org/article/S1542-…

I believe there's an opportunity to re-evaluate our approach to patients after #IPAA for #UC. 

#HansHerfarth and I discuss moving from a reactive ➡️ proactive approach in <a href="/AGA_CGH/">CGH</a> <a href="/UNCGastro/">UNC Gastroenterology</a>  

cghjournal.org/article/S1542-…
Crohn’s & Colitis Foundation IBD Pro (@ibdpronews) 's Twitter Profile Photo

You don't have to be an #IBD #pharmacist to register for our IBD Pharmacist Virtual Symposium on Saturday! Free to attend for any #GInurse, #APP, #gastroenterologist, etc, interested in topics like biologics, insurance, overlapping treatments, etc! crohnscolitisfoundation.org/professional/i…

#MondayNightIBD (@mondaynightibd) 's Twitter Profile Photo

🎯#GI #CRSurgery Do pt’s & disease factors affect the type of✂️ you recommend for #dysplasia in #IBD? 🗳️PreConvo Polls👇🏽 🆓#CME👉🏽bit.ly/MNIBD24-25 🗓️Join the convo June9 Nayantara Coelho Supported by educ grants AbbVie JanssenUS Takeda Where are you in your🩺

Aline Charabaty, MD, FACG, AGAF (@dcharabaty) 's Twitter Profile Photo

Impactful morning w #REACHIBD Crohn’s & Colitis Foundation IBD Pro 💎Representation matters to⏩science & health equity SandraQuezadaMD 💎Steps to be an effective advocate from clinic to the 🏛️ Ariel Jordan, MD 💎What does it mean to b a leader David T. Rubin, MD 💎Design your own career path & develop your brand🙋🏽‍♀️

Impactful morning w #REACHIBD <a href="/IBDProNews/">Crohn’s & Colitis Foundation IBD Pro</a> 
💎Representation matters to⏩science &amp; health equity <a href="/SandraQuezadaMD/">SandraQuezadaMD</a>
💎Steps to be an effective advocate from clinic to the 🏛️ <a href="/ariel_jordan22/">Ariel Jordan, MD</a>
💎What does it mean to b a leader <a href="/IBDMD/">David T. Rubin, MD</a>
💎Design your own career path &amp; develop your brand🙋🏽‍♀️
Beatriz Gros (@bealoquebea) 's Twitter Profile Photo

Exposure to biologics for IBD in utero or during breastfeeding has no negative impact on psychomotor development in infants Congratulations for this big registry and effort Maria Chaparro GETECCU

Crohn’s & Colitis Foundation IBD Pro (@ibdpronews) 's Twitter Profile Photo

🚨 We’re looking for TWO leaders to Chair the 2027–2029 Crohn’s & Colitis Congress — Clinical & Basic Science tracks! 👥 Shape the program 🌎 Lead alongside experts 📍 Kickoff in Las Vegas 2026 Apply now ➡️ bit.ly/2B6lJD5 #IBD #IBDPro

Neena S Abraham MD MACG FASGE AGAF (@neenasabrahammd) 's Twitter Profile Photo

If your career looks great on paper but feels unsustainable in real life, you’re not alone. Join me at #WIESUMMIT2025 and create a medical career that’s burnout-free, fully aligned, and that actually works for you! 🔗 womeninendo.org/wie-summit Dr. Amrita Sethi

Tauseef Ali MD, FACG AGAF FACP (@ibdtweets) 's Twitter Profile Photo

🚨 New Data on Risankizumab in Crohn’s Disease! Even initial nonresponders to IV induction saw benefits with extended treatment 💉 📈 At Week 24: ✅ Clinical Response: – 76% (180 mg SC) – 64% (360 mg SC) – 62% (1200 mg IV) ✅ Clinical Remission: Up to 45% ✅ Endoscopic

Beatriz Gros (@bealoquebea) 's Twitter Profile Photo

🔑ACG 2025 Preventive Care in IBD.Key Points: ✅ Vaccinations: - PCV20 or PCV21 instead of older schedules - Shingrix (2-dose recombinant) for all ≥50 yrs and ≥19 yrs if on immunosuppression - RSV vaccine for all ≥75 yrs & for 50–74 yrs w additional chronic conditions -

🔑ACG 2025 Preventive Care in IBD.Key Points:

✅ Vaccinations:
-  PCV20 or PCV21 instead of older schedules
- Shingrix (2-dose recombinant) for all ≥50 yrs and ≥19 yrs if on immunosuppression
- RSV vaccine for all ≥75 yrs &amp; for 50–74 yrs w additional chronic conditions
-
Tauseef Ali MD, FACG AGAF FACP (@ibdtweets) 's Twitter Profile Photo

🔬 JAKing up the options for perianal fistulas in Crohn’s disease! New post hoc analysis from 3 phase 3 trials (U-EXCEL, U-EXCEED, U-ENDURE) shows promising results for upadacitinib in patients with perianal fistulizing CD: ✅ 44.7% of patients on upadacitinib 45mg QD had

Suha Abushamma, MD (@suhaabushamma) 's Twitter Profile Photo

🗞️Check out the #REACHIBD summer newsletter for #GI fellows and early-career #IBD pros. Insightful patient stories, ☀️ #stoma tips to share, and more! David Fudman, MD Taha Qazi GutlessandGlamorous Mary Esna-Ashari Crohn’s & Colitis Foundation IBD Pro Crohn's & Colitis Foundation crohnscolitisfoundation.aflip.in/REACHIBDsummer…

Jalpa Devi (@jalpa_devi) 's Twitter Profile Photo

🌱 Tried out this new space for early-career IBD professionals, and it’s 💯 worth checking out! 💬A supportive spot to learn, connect, and share beyond the usual meetings. 📢 Early-career folks, don’t miss this! 📝 Drop your name to join!

🌱 Tried out this new space for early-career IBD professionals, and it’s 💯 worth checking out! 
💬A supportive spot to learn, connect, and share beyond the usual meetings.
📢 Early-career folks, don’t miss this!
📝 Drop your name to join!
@IBDConference (@ibdconference) 's Twitter Profile Photo

There is still time to join us in Chicago for #AIBDRegionals, July 26–27 or Virtually. Get the IBD updates you need now, including new therapies, team-based APP strategies, and case discussions. Register now: hubs.ly/Q03wWChJ0

There is still time to join us in Chicago for #AIBDRegionals, July 26–27 or Virtually. 

Get the IBD updates you need now, including new therapies, team-based APP strategies, and case discussions.

Register now: hubs.ly/Q03wWChJ0
Kelly Issokson MS RD LDN (she/her) (@gidietitian) 's Twitter Profile Photo

Just published Journal of Crohn's and Colitis! ECCO Consensus on Dietary Management of IBD: includes recommendations on diet therapies for disease management, nutrition optimization, and IBD prevention. academic.oup.com/ecco-jcc/advan…

Just published <a href="/JCC_IBD/">Journal of Crohn's and Colitis</a>! ECCO Consensus on Dietary Management of IBD: includes recommendations on diet therapies for disease management, nutrition optimization, and IBD prevention. academic.oup.com/ecco-jcc/advan…
IBDJournal & CC360 (@ibdjournals) 's Twitter Profile Photo

What are the risk factors for unplanned 🤰in women with IBD? 🧐 Data from PIANO 🎹 showed ⬆️ risk in women who: ➡️ Face 💰and educational barriers ⛔️ ➡️ Do not have a domestic partner ➡️ Belong to minority groups Erica Brenner MD, MSCR Uma Mahadevan Millie Long doi.org/10.1093/ibd/iz…

ACG (@amcollegegastro) 's Twitter Profile Photo

GI Training Programs: Apply for an ACG Edgar Achkar Visiting Professorship! Host nationally recognized speakers to enhance your program's educational offerings. Applications are due by August 20: ➡️gi.org/eavp #GIfellows, tag your program below!👇 Neena S Abraham MD MACG FASGE AGAF

GI Training Programs: Apply for an ACG Edgar Achkar Visiting Professorship!

Host nationally recognized speakers to enhance your program's educational offerings.

Applications are due by August 20:
➡️gi.org/eavp

#GIfellows, tag your program below!👇
<a href="/NeenaSAbrahamMD/">Neena S Abraham MD MACG FASGE AGAF</a>